Balint Sinko, Ph.D. (he/him/his)

Vice President, Innovation and Development
Pion Inc.

Bálint Sinkó received an M.Sc. in Pharmacy at Semmelweis University in 2007 and a Ph.D. in Pharmaceutical Sciences in 2012. As part of his Ph.D. project, he has developed a skin penetration model that has been licensed and commercialized by Pion Inc. Currently, he works for Pion Inc. as the leader of the development team. His research interest is focused on the formulation effect on intestinal and skin absorption. In these topics, he has authored or co-authored over 25 research articles in peer-reviewed journals and 1 book chapter. He is an industrial consultant for multiple Ph.D. students at University College London, Semmelweis University, and Budapest University of Technology and Economics. He also holds an honorary associate professor title at Semmelweis University.

Poster(s):

• (T1530-10-65) Artificial Extracellular Matrices Containing Human Collagen for In Vitro Analysis of Formulations Intended for Subcutaneous Injection
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET

• (M0930-03-21) Bioequivalence Prediction Based on In Vitro Flux Assay through the Example of Aripiprazole
  Monday, October 23, 2023

  9:30 AM – 10:30 AM ET

• (M1530-03-21) Predicting the Relative in Vivo performance of Nanoformed and Crystalline Bulk Piroxicam Solid Suspensions from in Vitro Flux Measurements
  Monday, October 23, 2023

  3:30 PM – 4:30 PM ET

• (T1330-03-21) Quantitating the Contributions of the Particle Drift Effect to In Vitro FLUX and the Application of Particle Drift Flux to Predictive Modelling
  Tuesday, October 24, 2023

  1:30 PM – 2:30 PM ET

• (M1130-09-57) Revisiting UV Spectroscopy for Real-Time Monitoring of Reversible Protein Unfolding
  Monday, October 23, 2023

  11:30 AM – 12:30 PM ET